Stock Events

Stock Events

Applied Biosciences 

$0.000100
1
+$0.00+0% Thursday 20:00

Statistics

Day High
0.0002
Day Low
0.0002
52W High
0.0002
52W Low
0.0001
Volume
520
Avg. Volume
46
Mkt Cap
2,200.3
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Jan 7
$2.20
Jan 6
$2.00
Jan 5
$0.60
Jan 4
$0.70
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

18FebExpected
Q3 2018
Q4 2018
Q4 2018
Q2 2019
Q3 2019
Q3 2019
Q4 2019
-0.16
-0.11
-0.06
-0.01
Expected EPS
N/A
Actual EPS
-0.1

Financials

-861.8%Profit Margin
Unprofitable
2015
2016
2017
2018
2019
2020
89,000Revenue
-767,000Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap32.55B
Illumina provides sequencing and array-based solutions for genetic analysis, directly competing in the genomics space with Applied Biosciences.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Thermo Fisher Scientific offers a broad range of services and products for research, analysis, discovery, and diagnostics, overlapping with Applied Biosciences' offerings.
Agenus
AGEN
Mkt Cap344.77M
Agenus is involved in the discovery and development of immunotherapies, which competes with Applied Biosciences' efforts in biotechnological healthcare solutions.
Bio-Rad Laboratories
BIO
Mkt Cap10.37B
Bio-Rad Laboratories provides a variety of research and clinical diagnostic products, competing in the life sciences and healthcare sectors like Applied Biosciences.
Qiagen NV
QGEN
Mkt Cap8.9B
Qiagen offers sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the molecular diagnostics field.
Pacific Biosciences of California
PACB
Mkt Cap435.16M
Pacific Biosciences of California offers sequencing systems that compete with Applied Biosciences' genomic analysis technologies.
Intellia Therapeutics
NTLA
Mkt Cap1.8B
Intellia Therapeutics is a leading genome editing company, competing in the CRISPR technology space relevant to Applied Biosciences' research and development focus.
Editas Medicine
EDIT
Mkt Cap485.31M
Editas Medicine operates in the genome editing field, directly competing with Applied Biosciences in the development of genomic medicines.
CRISPR Therapeutics
CRSP
Mkt Cap5.58B
CRISPR Therapeutics is focused on the development of gene-based medicines, competing in the genomic editing space with Applied Biosciences.
Danaher
DHR
Mkt Cap151.89B
Danaher Corporation operates in the life sciences, diagnostics, and environmental industries, offering products and services that compete across several of Applied Biosciences' key areas.

About

Applied Biosciences Corp. is dedicated to the creation and market launch of synthetic cannabinoid biopharmaceutical treatments. These advanced therapeutics are specifically designed to interact with the body's endocannabinoid system, aiming to address a wide array of diseases across diverse medical specialties. Furthermore, the company offers over-the-counter, THC-free CBD products directly to consumers, which are intended to support general health and well-being. It also provides specialized testing and analytical services to its customers. The firm was founded in 2014 and operates from its base in Beverly Hills, California.
Show more...
CEO
Christopher Michael Bridges
Employees
25
Country
United States
ISIN
US03815L1026

Listings

OTC Link
US
APPB

0 Comments

Share your thoughts

FAQ

What is Applied Biosciences stock price today?▼
The current price of APPB is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Applied Biosciences stock price performance more closely on the chart.
What is Applied Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Applied Biosciences stocks are traded under the ticker APPB.
Is Applied Biosciences stock price growing?▼
APPB stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Applied Biosciences has showed a +0% increase.
What is Applied Biosciences market cap?▼
Today Applied Biosciences has the market capitalization of 2,200.3
What were Applied Biosciences earnings last quarter?▼
APPB earnings for the last quarter are -0.1 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Applied Biosciences revenue for the last year?▼
Applied Biosciences revenue for the last year amounts to 89,000 USD.
What is Applied Biosciences net income for the last year?▼
APPB net income for the last year is -767,000 USD.
Does Applied Biosciences pay dividends?▼
Yes, APPB dividends are paid annual. The last dividend per share was 2.2 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Applied Biosciences have?▼
As of September 05, 2026, the company has 25 employees.
In which sector is Applied Biosciences located?▼
Applied Biosciences operates in the Health & Wellness sector.
When did Applied Biosciences complete a stock split?▼
The last stock split for Applied Biosciences was on October 24, 2016 with a ratio of 1:10.
Where is Applied Biosciences headquartered?▼
Applied Biosciences is headquartered in Beverly Hills, United States.